Erectile dysfunction in Parkinson's disease

Urology

Volumn 67, Issue 3, 2006, Pages 447-451

  Papatsoris, A G ^b   Deliveliotis, C ^b   Singer, C ^b   Papapetropoulos, S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; GPI 1485; LEVODOPA; NEUROIMMUNOPHILIN; PERGOLIDE MESILATE; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; ROPINIROLE; SILDENAFIL; TSUKUBAENOLIDE;

BRAIN DEPTH STIMULATION; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED HEADACHE; ELECTROSTIMULATION THERAPY; EPIDEMIOLOGICAL DATA; ERECTILE DYSFUNCTION; HOT FLUSH; HUMAN; HYPERSEXUALITY; NEUROPATHOLOGY; NONHUMAN; ORTHOSTATIC HYPOTENSION; PAINFUL ERECTION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

HUMANS; IMPOTENCE; MALE; PARKINSON DISEASE;

EID: 33644760376     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.10.017     Document Type: Review

References (51)

1. R. Rosen, J. Altwein, P. Boyle Lower urinary tract symptoms and male sexual dysfunction the multinational survey of the aging male (MSAM-7) Eur Urol 44 2003 637 649
2. A.G. Papatsoris, A. Triantafyllidis, A. Gekas Prevalence of erectile dysfunction in the European Union Asian J Androl 5 2003 255
3. R. Shabsigh, M.A. Perelman, D.C. Lockhart Health issues of men prevalence and correlates of erectile dysfunction J Urol 174 2005 662 667
4. H.A. Feldman, I. Goldstein, D.G. Hatzichristou Impotence and its medical and psychosocial correlates results of the Massachusetts Male Aging Study J Urol 151 1994 54 61
5. D.G. Hatzichristou Sildenafil citrate lessons learned from 3 years of clinical experience Int J Impot Res 14 suppl 1 2002 S43 S52
6. M.C. de Rijk, L.J. Launer, K. Berger Neurologic Diseases in the Elderly Research Group Prevalence of Parkinson's disease in Europe a collaborative study of population-based cohorts Neurology 54 2000 S21 S23
7. J.M. Fearnley, A.J. Lees Ageing and Parkinson's disease substantia nigra regional selectivity Brain 114 Pt 5 1991 2283 2301
8. R.G. Brown, M. Jahanshahi, N. Quinn Sexual function in patients with Parkinson's disease and their partners J Neurol Neurosurg Psychiatry 53 1990 480 486
9. R. Basson Sexuality and Parkinson's disease Parkinsonism Relat Disord 2 1996 177 185
10. C. Singer, W.J. Weiner, J.R. Sanchez-Ramos Sexual dysfunction in men with Parkinson's disease J Neurol Rehab 3 1989 199 204
11. M.M. Hoehn, M.D. Yahr Parkinsonism onset, progression and mortality Neurology 17 1967 427 442
12. P. Hobson, W. Islam, S. Roberts The risk of bladder and autonomic dysfunction in a community cohort of Parkinson's disease patients and normal controls Parkinsonism Relat Disord 10 2003 67 71
13. R. Sakakibara, H. Shinotoh, T. Uchiyama Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease Auton Neurosci 92 2001 76 85
14. G. Bronner, V. Royter, A.D. Korczyn Sexual dysfunction in Parkinson's disease J Sex Marital Ther 30 2004 95 105
15. O. Moore, T. Gurevich, A.D. Korczyn Quality of sexual life in Parkinson's disease Parkinsonism Relat Disord 8 2002 243 246
16. S. Papapetropoulos, D.C. Mash Psychotic symptoms in Parkinson's disease from description to etiology J Neurol 252 2005 753 764
17. H. Jacobs, A. Vieregge, P. Vieregge Sexuality in young patients with Parkinson's disease a population based comparison with healthy controls J Neurol Neurosurg Psychiatry 69 2000 550 552
18. H. Braak, E. Braak, D. Yilmazer Amygdala pathology in Parkinson's disease Acta Neuropathol (Berl) 88 1994 493 500
19. W.H. Jost Autonomic dysfunctions in idiopathic Parkinson's disease J Neurol 250 suppl 1 2003 I28 I30
20. A. Nehra, R.B. Moreland Neurologic erectile dysfunction Urol Clin North Am 28 2001 289 308
21. K. Wakabayashi, H. Takahashi Neuropathology of autonomic nervous system in Parkinson's disease Eur Neurol 38 suppl 2 1997 2 7
22. J.C. Holstege, H. Van Dijken, R.M. Buijs Distribution of dopamine immunoreactivity in the rat, cat and monkey spinal cord J Comp Neurol 376 1996 631 652
23. H. van Dijken, J. Dijk, P. Voom Localization of dopamine D2 receptor in rat spinal cord identified with immunocytochemistry and in situ hybridization Eur J Neurosci 8 1996 621 628
24. M.R. Zarrindast, S. Shokravi, M. Samini Opposite influences of dopaminergic receptor subtypes on penile erection Gen Pharmacol 23 1992 671 675
25. J.D. O'Sullivan, A.J. Hughes Apomorphine-induced penile erections in Parkinson's disease Mov Disord 13 1998 536 539
26. K.K. Chen, J.Y. Chan, L.S. Chang Dopaminergic neurotransmission at the paraventricular nucleus of hypothalamus in central regulation of penile erection in the rat J Urol 162 1999 237 242
27. G. Skagerberg, O. Lindvall Organization of diencephalic dopamine neurones projecting to the spinal cord in the rat Brain Res 342 1985 340 351
28. K.E. Andersson, H. Gemalmaz, K. Waldeck The effect of sildenafil on apomorphine-evoked increases in intracavernous pressure in the awake rat J Urol 161 1999 1707 1712
29. S. Lal, N.P. Nair, H.L. Iskandar Effect of domperidone on apomorphine-induced growth hormone secretion in normal men J Neural Transm 54 1982 75 84
30. F. Giuliano, J. Bernabe, K. McKenna Spinal proerectile effect of oxytocin in anesthetized rats Am J Physiol Regul Integr Comp Physiol 280 2001 R1870 R1877
31. F. Giuliano, J. Allard, O. Rampin Spinal proerectile effect of apomorphine in the anesthetized rat Int J Impot Res 13 2001 110 115
32. O. Ishizuka, B.J. Gu, O. Nishizawa Effect of apomorphine on intracavernous pressure and blood pressure in conscious, spinalized rats Int J Impot Res 14 2002 128 132
33. R. d'Emmanuele di Villa Bianca, R. Sorrentino, F. Roviezzo Peripheral relaxant activity of apomorphine and of a D1 selective receptor agonist on human corpus cavernosum strips Int J Impot Res 17 2005 127 133
34. E. Dula, W. Keating, P.F. Siami Apomorphine Study Group Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction Urology 56 2000 130 135
35. P. Nausieda, M. Stren, J. Hubble Pergolide monotherapy titration in Parkinson's disease Mov Disord 17 suppl 5 2002 87
36. M. Pohanka, P. Kanovsky, M. Bares Pergolide mesylate can improve sexual dysfunction in patients with Parkinson's disease the results of an open, prospective, 6-month follow-up Eur J Neurol 11 2004 483 488
37. P. Kanovsky, M. Bares, M. Pohanka Penile erections and hypersexuality induced by pergolide treatment in advanced, fluctuating Parkinson's disease J Neurol 249 2002 112 114
38. J. Fine, A.E. Lang Dose-induced penile erections in response to ropinirole therapy for Parkinson's disease Mov Disord 14 1999 701 702
39. K.J. Klos, J.H. Bower, K.A. Josephs Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy Parkinsonism Relat Disord 11 2005 381 386
40. H.I. Kaplan, B.J. Saddock, J.A. Grebb Synopsis of Psychiatry. 1994 Williams & Wilkins Baltimore
41. P.H. Lim, P. Moorthy, K.G. Benton The clinical safety of Viagra Ann NY Acad Sci 962 2002 378 388
42. B. Giammusso, R. Raffaele, I. Vecchio Sildenafil in the treatment of erectile dysfunction in elderly depressed patients with idiopathic Parkinson's disease Arch Gerontol Geriatr Suppl 8 2002 157 163
43. R. Raffaele, I. Vecchio, B. Giammusso Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson's disease Eur Urol 41 2002 382 386
44. M.D. Cheitlin, A.M. Hutter Jr, R.G. Brindis American College of Cardiology/American Heart Association ACC/AHA expert consensus document use of sildenafil (Viagra) in patients with cardiovascular disease J Am Coll Cardiol 33 1999 273 282
45. I.F. Hussain, C.M. Brady, M.J. Swinn Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension J Neurol Neurosurg Psychiatry 71 2001 371 374
46. J.D. O'Sullivan Apomorphine as an alternative to sildenafil in Parkinson's disease J Neurol Neurosurg Psychiatry 72 2002 681
47. P. Limousin, P. Krack, P. Pollak Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease N Engl J Med 339 1998 1105 1111
48. L. Castelli, P. Perozzo, M.L. Genesia Sexual well being in parkinsonian patients after deep brain stimulation of the subthalamic nucleus J Neurol Neurosurg Psychiatry 75 2004 1260 1264
49. K.R. Sandy AC pulsed electromagnetic fields-induced sexual arousal and penile erections in Parkinson's disease Int J Neurosci 99 1999 139 149
50. M.O. Poulter, K.B. Payne, J.P. Steiner Neuroimmunophilins a novel drug therapy for the reversal of neurodegenerative disease? Neuroscience 128 2004 1 6
51. V.L. Marshall, D.G. Grosset GPI-1485 (Guilford) Curr Opin Invest Drugs 5 2004 107 112